web analytics
December 10, 2016 / 10 Kislev, 5777

Posts Tagged ‘Mexico’

Jewish Photographer Dorothy Bohm Brings Back ‘Sixties London’ [video]

Wednesday, August 3rd, 2016

If you’re in London on vacation this month, here’s an opportunity to explore the streets of 1960s London through the lens of eminent photographer Dorothy Bohm. Born in 1924 to o a Jewish-Lithuanian family in Konigsberg, East Prussia, Bohm escaped Nazism in 1939 when she was sent to England to finish her schooling, armed with a Leica camera handed to her by her father as she was departing. She Graduated from Manchester College of Technology in 1942 and worked in leading portrait studio in central Manchester. In 1945 she married Louis Bohm, in ’46 she opened “Studio Alexander” in Manchester, and in 1947 visited Palestine for the first time. Between 1947 and 1955, she traveled to Switzerland, lived in Paris, lived in New York and San Francisco, traveled around the US and Mexico, until in 1956 she settled in Hampstead, North London, where she still lives.

Church Street market, Marylebone / Dorothy Bohm, Courtesy

Church Street market, Marylebone / Dorothy Bohm, Courtesy

She continued to travel and shoot around the planet, but her retrospective show that ends August 29 at the Jewish Museum London steps back in time to discover the diversity of life in London in the 1960s, with photographs focusing on its inhabitants from all walks of life, from schoolchildren to fashion-conscious young adults to market traders.

Dorothy Bohm: Sixties London, at the Ben Uri Gallery & Museum through August 29 2016.

Open Daily 10 AM – 5 PM (Fridays 10 AM – 2 PM). Last entrance is 30 minutes before closing.

Jewish Museum London, Raymond Burton House, 129-131 Albert Street, London NW1 7NB

Tel: +44 (0)20 7284 7384

JNi.Media

Philanthropist Marcus Katz Dead at 89

Wednesday, July 27th, 2016

Jewish philanthropist Marcus Katz, the Holocaust survivor renowned for his contribution to promoting the connection between halkha and modern life, passed away Tuesday night at age 89. His funeral will be conducted Thursday evening at Givat Shaul Mount Menuchot.

Katz established the Marcus Katz Award which for 41 years has been given to outstanding contributors to building harmony between Jewish law and tradition and the modern world, among them Rabbi Lord Jonathan Sacks, Rabbi Yehoshua Yeshaya Neuwirth, Rabbi Tzvi Herschel Shachter, Dr. Hanna Katan, and Rabbi Avi Gisser’s Mishpetei Eretz institute.

Born to a Hasidic family in Krakow, Poland, Markus Katz and members of his family fled to Palestine after the Nazi occupation. His mother, who spent the war in the labor camps, arrived in Haifa in 1946. In 1947 the family moved to Mexico, where Marcus became a principal of a Jewish school at age 20. He married Adina and the couple embarked on a life of business and industry, as well as the law, while constantly maintaining their relationship with the fledgling Jewish State.

They established the award in 1975, after the death of Markus’ mother, Golda. In 1985 the established the Zionist, modern Orthodox Emuna yeshiva in Mexico, catering to Jewish children from the first to the twelfth grade.

Over the years Adina and Markus Katz cultivated their close relationship with Israel, and developed personal friendships with many prominent figures in Israel’s society and politics, while continuing to influence through their charity work the lives of hundreds of thousands of Jews.

David Israel

Analysis: Can Ha’aretz Be More Racist than Donald Trump? You Betcha

Friday, June 10th, 2016

Late last month, Republican presidential candidate Donald Trump was condemned universally, when everyone but Ann Coulter called him a racist and a bigot for suggesting federal Judge Gonzalo Curiel should have recused himself from the Trump University trial because his parents were born in Mexico, and he, Trump, as he so aptly put it, is “building a wall.” Trump went on to tell various reporters that although the judge was born in Indiana, he must be a Trump hater, on account of “I’m building a wall.” He also told one reporter that the same obligation to recuse themselves should also apply to Muslim American judges in Trump-related cases (the candidate generates thousands of them, literally).

The fact that both House Speaker Paul Ryan (R-Wisconsin) and Senate Majority Leader Mitch McConnell (R- Kentucky) called on their party’s nominee to tone down the racism should tell us just how much they loathed his outburst.

On Friday morning, Ha’aretz op-ed writer Uri Misgav, in reviewing the recent Supreme Court decision that sided with the Chief Rabbinate and against the AG in prohibiting “alternative” kosher certifications, wrote the following:

“The ruling was by a majority of two to one. The two judges who preserved the corrupting power in the hands of the Rabbinate were Rubinstein and Noam Sohlberg. Both wear a yarmulke, [and are] religious Orthodox, who grew up and developed on the high road of Religious Zionism. They put the cats in charge of the cream. This was a very strangely composed panel. In fact, it was so strange that it’s not strange at all: of course it was intentional. With the assumption that it’s better to let the religious handle these issues which are close to their hearts. Except that the logic should have been the complete opposite of that. There’s a clear conflict of interests here. At stake was the tension between state and religion. The secular judge, incidentally, had the minority opinion.”

The paragraph above is dripping bigotry, not only accusing supreme court judges of being unable to examine a case on its merits, suspending their personal views—which is something we expect of every judge in every trial—but that somehow the powers-that-be on the court assigned the two religious Orthodox judges because the case belongs in their ghetto. The root of Trump’s bigotry and the root of Misgav’s bigotry are the same: they both assume that judges belonging to the group they hate are inevitably partial, interested parties in the cases they try.

But then Misgav focuses on Judge Sohlberg, calling him a criminal, because he resides in Alon Shvut, at the heart of Gush Etzion, an area which even Misgav agrees will never be handed over to Arab rule, even as part of a two-state agreement. Writing for a newspaper that has printed many miles of allegations against rightwing activists and politicians who have threatened the Supreme Court for its unprecedented activism, Misgav actually exposed Sohlberg to prosecution by a European court as a war criminal. The scenario is simple: Judge Sohlberg lands in Brussels, someone on the same El Al flight identifies him and calls over the Gendarmes, showing them the English translation of Misgav’s attack, demanding that Sohlberg be taken into custody until the war crime charges against him are verified. Unrealistic? Probably, but when MK Moti Yogev (Habayit Hayehudi) last summer announced, “We have to take the blade of a D-9 [bulldozer] to the High Court of Justice,” Ha’aretz took his expression of rage at face value.

It appears Ha’aretz is willing to see Israeli high court justices’ lives be put in jeopardy just to advance the paper’s political ends. So much for tolerance and liberalism.

David Israel

Trump May Come to Israel in July to Visit the Southern Wall

Thursday, June 2nd, 2016

Donald Trump is planning to visit Israel before the Republican national convention in July, according to persistent reports, although his campaign is denying it. New York Magazine on Wednesday cited four sources who say Trump’s Jewish son-in-law, Jared Kushner, together with associates of Sheldon Adelson are working on the trip. Trump was planning to visit Israel before the start of the primaries and was hoping for Netanyahu’s endorsement, but then Bibi said he wasn’t planning to endorse anyone. Perhaps the fact that Adelson is involved this time around means that the Israeli PM will at least give the candidate the royal treatment he expects.

“This is a typical time frame when a general-election candidate has an opportunity to flex his foreign-policy muscles,” a Trump staffer told NY Mag.

Some Internet news sources have suggested that Trump may be coming to Israel not for the endorsements, and not to gain favor with the hard-line pro-Israel crowd—he’s got them already. Instead, Trump is going to see the wall. Not the Western Wall, but the 150 mile fence Israel has erected along its border with Egypt, which caused the number of illegal African migrant workers getting through to drop from thousands to single digits annually.

Jewish Insider quoted Trump’s recent book “Crippled America,” where he states, “Walls work. The Israelis spent $2 million per kilometer to build a wall – which has been hugely successful in stopping terrorists from getting into the country. Ironically, some of the same people who claim we shouldn’t build a wall cite the success of Israel’s wall. While obviously we don’t face the same level of terrorist threat as our closest Middle East ally, there is no question about the value of a wall in the fight against terrorism.”

The Negev security fence, which is supported by a heavy military detail, has also been remarkably effective at preventing the ISIS affiliates in the Sinai from infiltrating. Of course, Israel did not ask Egypt to pay for the wall, the way Trump promises to do with Mexico, and the US southern border is not 150 but 1,989 miles. Otherwise, though, Trump could gain points by pointing to the Israeli approach to sealing the border and smiling victoriously in the desert sun.

Of course, if liberal folks live up to their word and flee to Canada after a Trump win, Israel could be cashing in on its border fence technology from two countries.

David Israel

Israel’s Material Well-Being and National Wealth Stats Up Across the Board

Wednesday, May 4th, 2016

Real national disposable income per capita in Israel has gone up by 1.7% in 2014 compared with the year before, reaching a level of 119% compared with the year 2000, Israel’s Central Board of Statistics announced on Wednesday.

In 2014, the government debt as a percentage of GDP (65%) was lower than that of France (85%), Spain (88%), the UK (94%), the US (98%), and Italy (127%). It was higher than Germany’s (48%), the Czech Republic (46%), Sweden (44%), Turkey (37%), Switzerland (21%), and Norway (17%).

Between the years 2008-2011 there was a moderate rise in net income inequality in Israel (according to the Gini coefficient, a.k.a. the Gini index or Gini ratio — a measure of statistical dispersion intended to represent the income distribution of a nation’s residents, which is the most commonly used measure of inequality.) It was followed by a downward trend in the Gini index until 2013, but remains high in Israel, compared with other OECD countries — higher than the US, Turkey, Mexico and Chile.

In 2013, the net annual income per standard capita was 91,604 shekel ($24,283), a rise of 5% compared with the year before, in 2013 rates. The net annual reported income per standard capita in Jewish households was double the amount in Arab households.

In 2013, Israel’s household debt as a percentage of GDP (47%) was significantly lower than most other OECD countries, such as Spain (79%), France (63%), Germany (56%), and Italy (49%). It was still higher than that of Poland (35%), Slovakia (32%), and Hungary (31%).

58% of Israelis ages 20 and up were satisfied with their economic situation in 2014: 59% of men, 57% of women.

Israeli Jews were more satisfied than Israeli Arabs — 60% vs. 48% respectively.

JNi.Media

Smugglers’ Cross-Border Tunnel Discovered in San Diego

Thursday, April 21st, 2016

It’s not only Israel contending with tunnels, although for Israel tunnels pose an existential threat.

For the third time this month, a cross-border tunnel was discovered Wednesday (April 20) leading from Mexico to California. Authorities seized seven tons of marijuana and more than a ton of cocaine.

The tunnel, measuring nearly half a mile, is believed to be the longest ever found in California. It was equipped with a rail system, ventilation, lights and a large elevator, making delivery of the smuggled goods much easier and more efficient. Some tunnels along the U.S.-Mexico border have been discovered with hydraulic lifts and electric rail cards, according to Fox News.

The exit on the U.S. side was about three feet wide. Six people were arrested last Friday in San Diego and charged with constructing tunnels and other drug-related crimes. They were not identified and their affiliation is not known.

There are numerous drug cartels doing “business” throughout Latin America, including a number who carry out transactions with Lebanon’s Iranian-backed Hezbollah terrorist organization.

Agents found 1,600 pounds of marijuana inside the tunnel. Another 11,000 pounds of cannabis and 2,242 pounds of cocaine were found in the truck that had been collected from the handy trash bin strategically placed to hide the mouth of the tunnel, as a pickup site for smugglers. In addition, another 1,430 pounds of marijuana were found in the bin.

Hana Levi Julian

Weizmann Institute Drug Approved for Prostate Cancer Therapy in Mexico

Tuesday, January 5th, 2016

(JNi.media) A therapy invented at the Weizmann Institute of Science and clinically developed in collaboration with Steba Biotech (Luxembourg) has been approved by Cofepris, Mexico’s health authority, for the focal treatment of early-stage prostate cancer.

The therapy involves a laser and a novel drug, TOOKAD® Soluble. A successful Phase III clinical trial in Latin America (Mexico, Peru and Panama), involving 80 patients, confirmed the high rate of local cures and minimal side effects already reported in Phase II clinical trials, as evidenced by negative biopsies and maintenance of patients’ potency, continence and overall quality of life.

The marketing approval in Mexico comes in the wake of the recent completion of a second Phase III clinical trial in Europe. This randomized pivot study compared disease progression, cancer-free rate and urinary and erectile functions in patients treated with TOOKAD® Soluble and those undergoing active surveillance with a follow-up of two years. It involved more than 400 patients at 43 hospitals in 11 European countries and is currently under evaluation by the European Medicines Agency (EMA).

The approved therapy follows a new paradigm developed by Prof. Yoram Salomon of the Biological Regulation Department and Prof. Avigdor Scherz of the Plant and Environmental Sciences Department in the framework of photodynamic therapy. It comprises an intravenous infusion of TOOKAD® Soluble, immediately followed by near-infrared laser illumination through thin optic fibers that are inserted into the cancer prostatic tissue, under ultrasound control. Tookad® Soluble was first synthesized in Scherz’s lab from bacteriochlorophyll, the photosynthetic pigment of certain aquatic bacteria that draw their energy supply from sunlight. The drug stays in the patient’s blood circulation until it totally clears 3-4 hours later, and it shows no toxicity. Confined illumination of the diseased tissue activates the circulating drug locally, resulting in the extensive generation of short-lived toxic molecules: oxygen and nitric oxide radicals. These highly reactive molecules initiate rapid occlusion and destruction of the tumor blood vessels, followed by necrotic death of the entire tumor while sparing nearby structures and their functions. The use of near-infrared illumination, together with the rapid clearance of the drug from the body and the unique non-thermal mechanism of action, makes it possible to safely treat large, deeply embedded cancerous tissue using a minimally invasive procedure. The recent marketing approval was provided to both the drug (TOOKAD® Soluble) and the laser illumination device (Laser), together designated Vascular Targeted Photodynamic Therapy (VTP) with TOOKAD® Soluble.

In the currently approved focal therapy setting, TOOKAD® Soluble VTP (TS-VTP) is a day-case procedure lasting approximately 90 minutes. Patients are released a few hours later and can return to normal activities within a few days, with none of the side effects frequently associated with prostate removal by surgery or radiotherapy. This new minimally invasive technology offers a good alternative to patients diagnosed with early-stage prostate cancer. The number of these patients has dramatically increased in the last two decades due to widespread screening relying on levels of prostate specific antigen (PSA). This population faces the dilemma of undergoing the radical treatment of prostate removal with the risk of high morbidity, or remaining under active surveillance with increased risk of further cancer progression.

Tookad® Soluble answers an unmet need in providing this category of patients with an appropriate treatment, which combines good efficacy with a preservation of the quality of life.

Weizmann institute and Steba Biotech are currently pursuing an extensive oncological research program in collaboration with several clinical groups at Memorial Sloan Kettering Cancer Center in New York City. Four clinical studies for more advanced prostate cancer and other oncological indications stemming from this research are scheduled to start in 2016.

JNi.Media

Printed from: http://www.jewishpress.com/news/breaking-news/weizmann-institute-drug-approved-for-prostate-cancer-therapy-in-mexico/2016/01/05/

Scan this QR code to visit this page online: